| Form of release | Blister (25 tablets), Pack (100 tablets) |
|---|---|
| International Name | Stenabolic (SR-9009) |
| Chemical Name | Ethyl-3-(((4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)pyrrolidine-1-carboxylate |
| Type of Drug Combination | Rev-Erbα / Rev-Erbβ agonist |
| Molecular Formula | C20H24ClN3O4S |
| Molecular Weight | 437.94 g/mol |
| Halflife | 4–6 hours, 4–6 hours |
| Mechanism of Action | Activation of Rev-Erbα protein, which affects circadian rhythms, lipid and glucose metabolism, energy metabolism, and mitochondrial activity |
| Anabolic Activity | No |
| Androgenic Activity | No |
| Main Effects | Increased endurance, accelerated metabolism, fat burning, improved recovery, increased mitochondrial activity |
| Side Effects | Possible sleep disturbances (when taken late), irritability, nausea, fatigue, decreased glucose levels (rare) |
| thenecessityofpct | No, No |
| Recommended Dosage | 10–30 mg per day |
| Course Duration | 6–8 weeks |
| Reception Hours | In the morning and before training |
| Impact on Estrogens | No |
| Impact on the Liver | Moderate |
| Storage | In a dry, cool place, protected from light, at a temperature not exceeding 25°C, In a dry, cool place, protected from light, at a temperature not exceeding 25°C |
| Use by Women | Acceptable, does not cause virilization |
| Detection Period in the body | Up to 1–2 weeks |
